Timsit J F, Farkas J C, Boyer J M, Martin J B, Misset B, Renaud B, Carlet J
Division of Réanimation Polyvalente, Hôpital Saint Joseph, Paris, France.
Chest. 1998 Jul;114(1):207-13. doi: 10.1378/chest.114.1.207.
To evaluate the incidence and risk factors for catheter-related central vein thrombosis in ICU patients.
Observational prospective multicenter study.
An 8-bed surgical ICU, a 10-bed surgical cardiovascular ICU, and a 10-bed medical-surgical ICU.
During an 18-month period, 265 internaljugular or subclavian catheters were included. Veins were explored by duplex scanning performed just before or < 24 h after catheter removal. Suspected risk factors of catheter-related central vein thrombosis were recorded.
None.
Fifty-seven catheters were excluded from the analysis. Therefore 208 catheters were analyzed. Mean age of patients was 64+/-15 years, simplified acute physiologic score was 12+/-5, organ system failure score at insertion was 1+/-1, and mean duration of catheterization was 9+/-5 days. A catheter-related internal jugular or subclavian vein thrombosis occurred in 33% of the cases (42% [95% confidence interval (CI), 34 to 49%] and 10% [95% CI, 3 to 18%], respectively). Thrombosis was limited in 8%, large in 22%, and occlusive in 3% of the cases. Internal jugular route (relative risk [RR], 4.13; 95% CI, 1.72 to 9.95), therapeutic heparinization (RR 0.47; 95% CI, 0.23 to 0.99), and age >64 years (RR, 2.44; 95% CI, 2.05 to 3.19) were independently associated with catheter-related thrombosis. Moreover, the risk of catheter-related sepsis was 2.62-fold higher when thrombosis occurred (p=0.011).
Catheter-related central vein thrombosis is a frequent complication of central venous catheterization in ICU patients and is closely associated with catheter-related sepsis.
评估重症监护病房(ICU)患者中心静脉导管相关血栓形成的发生率及危险因素。
前瞻性观察性多中心研究。
一个有8张床位的外科ICU、一个有10张床位的外科心血管ICU以及一个有10张床位的内科-外科ICU。
在18个月期间,纳入265根颈内静脉或锁骨下静脉导管。在拔管前或拔管后<24小时通过双功超声扫描探查静脉。记录导管相关中心静脉血栓形成的可疑危险因素。
无。
57根导管被排除在分析之外。因此,对208根导管进行了分析。患者的平均年龄为64±15岁,简化急性生理学评分是12±5,置管时器官系统功能衰竭评分为1±1,平均置管时间为9±5天。33%的病例发生了导管相关的颈内静脉或锁骨下静脉血栓形成(分别为42%[95%置信区间(CI),34%至49%]和10%[95%CI,3%至18%])。8%的病例血栓形成局限,22%为大面积血栓,3%为闭塞性血栓。颈内静脉置管途径(相对危险度[RR],4.13;95%CI,1.72至9.95)、治疗性肝素化(RR 0.47;95%CI,0.23至0.99)以及年龄>64岁(RR,2.44;95%CI,2.05至3.19)与导管相关血栓形成独立相关。此外,血栓形成时导管相关脓毒症的风险高2.62倍(p=0.011)。
导管相关中心静脉血栓形成是ICU患者中心静脉置管的常见并发症,且与导管相关脓毒症密切相关。